Senior insider sale
Chief Commercial Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$319.8K
39.06K shares
KARAS ERIC plans to sell 39.06K shares of ARS PHARMACEUTICALS, INC. valued at approximately $319.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Employee Stock Purchase Plan
Cash
Employee Stock Purchase Plan
Cash
Employee Stock Purchase Plan
Cash
Employee Stock Purchase Plan
Cash
Employee Stock Purchase Plan
Cash
Employee Stock Purchase Plan
Cash
Employee Stock Purchase Plan
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Employee Stock Purchase Plan Cash | 1.89K | — |
12/31/2025 | Employee Stock Purchase Plan Cash | 1.86K | — |
6/30/2025 | Employee Stock Purchase Plan Cash | 2.62K | — |
12/31/2024 | Employee Stock Purchase Plan Cash | 2K | — |
6/28/2024 | Employee Stock Purchase Plan Cash | 2.48K | — |
12/29/2023 | Employee Stock Purchase Plan Cash | 1.23K | — |
6/30/2023 | Employee Stock Purchase Plan Cash | 1.98K | — |
| Total | 14.06K | ||
Completed
Units to sell
25K
Market value
$250.0K
Planned — Approximate Date
Units to sell
14.06K
Market value
$69.8K
Units
39.06K
Value
$319.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/12/2026 | 25K | $250.0K | — | Completed |
| Planned — Approximate Date | ||||
9/11/2026 | 14.06K | $69.8K | NASDAQ | Planned |
| Total | 39.06K | $319.8K | ||